Jed Wulfekotte is a litigation partner at Stein Mitchell Beato & Missner LLP. He handles a wide variety of complex commercial litigation matters, including pharmaceutical and healthcare litigation, engineering and construction disputes, and business torts; False Claims Act investigations and litigation; internal investigations; and government investigations with various state and federal agencies, including the Department of Justice, State Attorneys General Offices, the Department of Health and Human Services, the Food and Drug Administration, the Securities and Exchange Commission, and the Department of Defense.
SuperLawyers® Rising Star Business Litigation, Washington, D.C. (2014-2017)
2018 Best Lawyers Under 40 Award, National Asian Pacific American Bar Association (NAPABA)
American University Washington College of Law, J.D., cum laude
- Articles Editor, Administrative Law Review
- Moot Court Honor Society
- Dean's Fellow, Whistleblower and Administrative Law
Muhlenberg College, B.A., cum laude, Philosophy and Business Administration
- District of Columbia
- United States District Court for the Eastern District of Virginia
- United States Bankruptcy Court for the Eastern District of Virginia
Community & Professional
President, Asian Pacific American Bar Association of the Greater Washington, D.C. Area (APABA-DC), 2015-2016; President-Elect, 2014-2015; Immediate Past President, 2016-2017
Commissioner, D.C. Office of Asian and Pacific Islander Affairs, 2014-2016
President, Asian Pacific American Bar Association Educational Fund (AEF) Board of Directors, 2013-2014; Vice-President, 2012-2014
- Counsel for qui tam relator in United States ex rel. Marc Baker v. Walgreen Co., Civ. No. 12 Civ. 0300 (JPO) (S.D.N.Y.). Obtained a combined $110 million settlement under the False Claims Act in connection with Walgreen’s submission of false usual and customary prices to Medicaid for prescription drugs and its enrollment of government healthcare beneficiaries in a Prescription Savings Club.
- Counsel to Advarra, Inc., a portfolio company of Linden Capital Partners, in Legarda et al. v. Celerion, Inc., CV2016-009119 (Ariz. Super. Ct. Maricopa Cty.) related to Advarra’s approval of an FDA-regulated clinical drug study. Secured a dismissal of all claims against Advarra at summary judgment following extensive briefing and lengthy oral argument. Subsequently secured denials of various motions brought by the plaintiff, including a motion for leave to amend the complaint to add new claims.
- Counsel for artist management company and music group in a commercial litigation brought by the group's former management company. Obtained dismissal of all claims prior to discovery.
- Counsel for international pharmaceutical company in a product liability case. Secured dismissal of all claims with limited discovery.
- Counsel for leading engineering, procurement and construction contractor in a large commercial arbitration regarding a multi-billion dollar power plant project. The matter resulted in a complete defense award for the client following a 19-day arbitration hearing.
- Counsel for Relator in United States ex rel. Dinesh S. Thakur v. Ranbaxy Laboratories Limited, Civ. No. 1:07-cv-00962-JFM (D. Md.). Obtained the largest drug safety settlement in history against India’s largest generic drug manufacturer in the amount of $500 million.
- Counsel for engineering, procurement and construction contractor in False Claims Act investigations related to power plant projects.
- Counsel for Relators in United States ex rel. Michael R. Jones, M.D., Paula W. Hollingsworth, M.D., and Michael G. Rukavina, M.D. v. St. Joseph Health System et al., Civ. No. 11-cv-81-GFVT (E.D. Ky). Obtained $16.5 million settlement against a hospital chain under the False Claims Act for submitting false claims to Medicare and the Kentucky Medicaid programs for a variety of medically unnecessary cardiac procedures performed in patients.
- Counsel for international union in complex civil litigation under the Racketeering Influenced and Corrupt Practices Act (RICO). Obtained favorable settlement for the client prior to trial.
- Counsel for mentally ill victim of sexual abuse in an assisted living facility. Obtained civil monetary damages on the client’s behalf against her psychiatrist following a two-week jury trial in Virginia Circuit Court.
- Legarda et al. v. Celerion, Inc., CV2016-009119 (Ariz. Super. Ct. Maricopa Cty.): Counsel for Advarra Inc. in connection with its review and approval of an FDA-regulated clinical drug study. Secured a dismissal of all claims against Advarra at summary judgment following extensive briefing and lengthy oral argument. Subsequently secured denials of various motions brought by the plaintiff, including motions for reconsideration and for leave to amend the complaint to add new claims.
News & Media Mentions
- Stein Mitchell Represented a Successful Whistleblower in $50 million Settlement of a Civil Fraud Lawsuit01.19.2017
- Stein Mitchell Muse Cipollone & Beato LLP Announces $16.5 Million False Claims Act Settlement for Unnecessary Heart Procedures Performed by St. Joseph Health SystemPress Release
- Press Release
- Stein Mitchell Muse Cipollone & Beato LLP Announces Largest Generic Drug Whistleblower Settlement in HistoryPress Release